Site navigation

Navigation

Venous thromboembolism - rivaroxaban

Rivaroxaban for the prevention of venous thromboembolism

Summary

This guidance is about when rivaroxaban should be used to reduce the risk of thromboembolism in adults who have surgery to replace their hip or knee joints in the NHS in England and Wales. It explains guidance (advice) from NICE (the National Institute for Health and Clinical Excellence). It does no ...

Read the complete summary


Guidance documents

Implementing this guidance

Other information

We will consult on our review plans for this guidance in February 2012

About this guidance

Technology appraisals TA170

Issued: April 2009

How this guidance was produced

See also:

See this guidance in practice:

Order printed copies of this guidance